Meihua Huang

Title: Meihua Huang: Innovator in Biomedicine

Introduction

Meihua Huang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedicine, particularly through his innovative patents. With a total of 4 patents, Huang's work focuses on developing compounds that exhibit improved pharmacological properties.

Latest Patents

One of Huang's latest patents is for selective dihydropyrrolopyrimidine JAK2 inhibitors. This invention relates to a selective JAK2 inhibitor or a pharmaceutically acceptable salt thereof. Compared to prior art, the compounds provided by this invention demonstrate better inhibitory activity for Janus Kinase and significantly improved selectivity for JAK2 targets. Additionally, the preferred compounds exhibit favorable pharmacokinetic properties, making them potential candidates for development as selective JAK2 inhibitors.

Another notable patent is for a pyridine sulfonamide phosphate compound, along with its preparation method and uses. This invention highlights the compound's high solubility, stability, and ease of preparation, which are advantageous for industrial-scale medical applications.

Career Highlights

Huang has worked with several reputable companies in the pharmaceutical sector, including Shanghai Xunhe Pharmaceutical Technology Co. Ltd. and Chengdu Jinrui Foundation Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in biomedicine and innovation.

Collaborations

Huang has collaborated with notable colleagues, including Yongyong Zheng and Hua Jin, who is a woman. These collaborations have likely enriched his research and development efforts in the field.

Conclusion

Meihua Huang is a distinguished inventor whose work in biomedicine has led to the development of innovative compounds with significant therapeutic potential. His contributions continue to advance the field and hold promise for future medical applications.